The DOI matches its Crossref record; 80 of the 80 references it cites were found in a registry or an index.
Tumor-derived spheroids: Relevance to cancer stem cells and clinical applications
Open accessAbstract
Recently, many types of in vitro 3-D culture systems have been developed to recapitulate the in vivo growth conditions of cancer. The cancer 3-D culture methods aim to preserve the biological characteristics of original tumors better than conventional 2-D monolayer cultures, and include tumor-derived organoids, tumor-derived spheroids, organotypic multicellular spheroids, and multicellular tumor spheroids. The 3-D culture methods differ in terms of cancer cell sources, protocols for cell handling, and the required time intervals. Tumor-derived spheroids are unique because they are purposed for the enrichment of cancer stem cells (CSCs) or cells with stem cell-related characteristics. These spheroids are grown as floating spheres and have been used as surrogate systems to evaluate the CSC-related characteristics of solid tumors in vitro. Because eradication of CSCs is likely to be of clinical importance due to their association with the malignant nature of cancer cells, such as tumorigenicity or chemoresistance, the investigation of tumor-derived spheroids may provide invaluable clues to fight against cancer. Spheroid cultures have been established from cancers including glioma, breast, colon, ovary, and prostate cancers, and their biological and biochemical characteristics have been investigated by many research groups. In addition to the investigation of CSCs, tumor-derived spheroids may prove to be instrumental for a high-throughput screening platform or for the cultivation of CSC-related tumor cells found in the circulation or body fluids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Figures
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“3D patient-derived tumor models of CRC (i.e., organoid and spheroid cultures) allow maintenance and expansion of functionally relevant cell subfractions and harbor the patients' individual genetic lesions (Ishiguro et al., 2017;van de Wetering et al., 2015).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
In the citing paper
“Moreover, TICs that have the capacity to self-renew and maintain long-term tumor growth are usually rare within the tumor mass but highly enriched within spheroid cultures (Dieter et al., 2011;Ishiguro et al., 2017).”
From Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer (2021) · cites this paper as Ishiguro et al., 2017
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Prospective identification of tumorigenic breast cancer cells
Al‐Hajj, M., Wicha, M. S., Benito‐Hernández, A., Morrison, S. J., & Clarke, M. F. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0530291100 · Cited by 10,579
A cell initiating human acute myeloid leukaemia after transplantation into SCID mice
Lapidot, T., Sirard, C., Vormoor, J., Murdoch, B., Hoang, T., Caceres-Cortes, J., Minden, M., Paterson, B., Caligiuri, M. A., & Dick, J. E. (1994) · Nature · doi:10.1038/367645a0 · Cited by 4,783
Reynolds, B. A., & Weiss, S. (1992) · Science · doi:10.1126/science.1553558 · Cited by 4,482
Identification and expansion of human colon-cancer-initiating cells
Ricci‐Vitiani, L., Lombardi, D. G., Pilozzi, E., Biffoni, M., Todaro, M., Peschle, C., & Maria, R. D. (2006) · Nature · doi:10.1038/nature05384 · Cited by 4,001
Sato, T., Stange, D. E., Ferrante, M., Vries, R. G. J., van Es, J. H., van den Brink, S., van Houdt, W. J., Pronk, A., van Gorp, J., Siersema, P. D., et al. (2011) · Gastroenterology · doi:10.1053/j.gastro.2011.07.050 · Cited by 3,753
Modeling Development and Disease with Organoids
Clevers, H. (2016) · Cell · doi:10.1016/j.cell.2016.05.082 · Cited by 3,196
Clarke, M. F., Dick, J. E., Dirks, P. B., Eaves, C., Jamieson, C., Jones, D. L., Visvader, J., Weissman, I. L., & Wahl, G. (2006) · Cancer Research · doi:10.1158/0008-5472.can-06-3126 · Cited by 3,124
The third dimension bridges the gap between cell culture and live tissue
Pampaloni, F., Reynaud, E. G., & Stelzer, E. H. K. (2007) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm2236 · Cited by 2,817
In vitro propagation and transcriptional profiling of human mammary stem/progenitor cellsPreprint
Dontu, G., Abdallah, W. M., Foley, J. M., Jackson, K. W., Clarke, M. F., Kawamura, M., & Wicha, M. S. (2003) · Genes & Development · doi:10.1101/gad.1061803 · Cited by 2,413
Lee, J., Kotliarova, S. E., Kotliarov, Y., Li, A., Su, Q., Donin, N. M., Pastorino, S., Purow, B. W., Christopher, N., Zhang, W., et al. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.03.030 · Cited by 2,345
Cited by
Sorted by citations
Stearoyl-CoA Desaturase 1 as a Therapeutic Target for the Treatment of Cancer
Tracz‐Gaszewska, Z., & Dobrzyń, P. (2019) · Cancers · doi:10.3390/cancers11070948 · Cited by 253
Podoplanin in Inflammation and Cancer
Quintanilla, M., Montero-Montero, L., Renart, J., & Martín-Villar, E. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20030707 · Cited by 241
Weng, C.-H., Chen, L.-Y., Lin, Y., Shih, J., Lin, Y.-C., Tseng, R.-Y., Chiu, A.-C., Yeh, Y.-H., Liu, C., Lin, Y., et al. (2018) · Oncogene · doi:10.1038/s41388-018-0454-2 · Cited by 239
Multicellular Tumor Spheroids (MCTS) as a 3D In Vitro Evaluation Tool of Nanoparticles
Lu, H., & Stenzel, M. H. (2018) · Small · doi:10.1002/smll.201702858 · Cited by 234
Modeling tumor cell adaptations to hypoxia in multicellular tumor spheroids
Riffle, S., & Hegde, R. S. (2017) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-017-0570-9 · Cited by 231
Zhou, Z., Cong, L., & Cong, X. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.762184 · Cited by 187
Hua, F., Shang, S., Yang, Y.-W., Zhang, H., Xu, T., Yu, J., Zhou, D., Cui, B., Li, K., Lv, X., et al. (2018) · Gastroenterology · doi:10.1053/j.gastro.2018.10.031 · Cited by 172
m6A-RNA Demethylase FTO Inhibitors Impair Self-Renewal in Glioblastoma Stem Cells
Huff, S. E., Tiwari, S. K., Gonzalez, G. M., Wang, Y., & Rana, T. M. (2021) · ACS Chemical Biology · doi:10.1021/acschembio.0c00841 · Cited by 173
Patient-Derived Glioma Models: From Patients to Dish to Animals
da Hora, C. C., Schweiger, M. W., Würdinger, T., & Tannous, B. A. (2019) · Cells · doi:10.3390/cells8101177 · Cited by 154
Promising Applications of Tumor Spheroids and Organoids for Personalized Medicine
Gilazieva, Z., Ponomarev, A. S., Rutland, C. S., Rizvanov, A. A., & Solovyeva, V. V. (2020) · Cancers · doi:10.3390/cancers12102727 · Cited by 163
Understanding cell‐cell communication and signaling in the colorectal cancer microenvironment
AlMusawi, S., Ahmed, M., & Nateri, A. S. (2021) · Clinical and Translational Medicine · doi:10.1002/ctm2.308 · Cited by 152
Yi, Y., Kim, H. J., Zheng, M., Mi, P., Naito, M., Kim, B. S., Min, H. S., Hayashi, K., Perche, F., Toh, K., et al. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.01.006 · Cited by 129
Ki-67 regulates global gene expression and promotes sequential stages of carcinogenesis
Mrouj, K., Andrés-Sánchez, N., Dubra, G., Singh, P., Sobecki, M., Chahar, D., Alghoul, E., Aznar, A. B., Prieto, S., Pirot, N., et al. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2026507118 · Cited by 127
Lee, J. M., Park, D. Y., Yang, L., Kim, E. J., Ahrberg, C. D., Lee, K., & Chung, B. G. (2018) · Scientific Reports · doi:10.1038/s41598-018-35216-7 · Cited by 133
Management and potentialities of primary cancer cultures in preclinical and translational studies
Miserocchi, G., Mercatali, L., Liverani, C., Vita, A. D., Spadazzi, C., Pieri, F., Bongiovanni, A., Recine, F., Amadori, D., & Ibrahim, T. (2017) · Journal of Translational Medicine · doi:10.1186/s12967-017-1328-z · Cited by 126
Bae, H., Song, G., & Lim, W. (2020) · Pharmaceutics · doi:10.3390/pharmaceutics12060488 · Cited by 123
Organoids with cancer stem cell-like properties secrete exosomes and HSP90 in a 3D nanoenvironment
Eguchi, T., Sogawa, C. A., Okusha, Y., Uchibe, K., Iinuma, R., Ono, K., Nakano, K., Murakami, J., Itoh, M., Arai, K., et al. (2018) · PLoS ONE · doi:10.1371/journal.pone.0191109 · Cited by 123
Gheytanchi, E., Naseri, M., Karimi‐Busheri, F., Atyabi, F., Mirsharif, E. S., Bozorgmehr, M., Ghods, R., & Madjd, Z. (2021) · Cancer Cell International · doi:10.1186/s12935-021-01898-9 · Cited by 118
3D Bioprinting of Tumor Models for Cancer Research
Kang, Y., Datta, P., Shanmughapriya, S., & Ozbolat, I. T. (2020) · ACS Applied Bio Materials · doi:10.1021/acsabm.0c00791 · Cited by 112
Targeting post-translational histone modifying enzymes in glioblastoma
Kunadis, E., Lakiotaki, E., Korkolopoulou, P. A., & Piperi, C. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107721 · Cited by 113
Advances in Stigmasterol on its anti-tumor effect and mechanism of action
Zhang, X., Wang, J., Zhu, L., Wang, X., Meng, F., Xia, L., & Zhang, H. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1101289 · Cited by 113
Natural and Synthetic Biomaterials for Engineering Multicellular Tumor Spheroids
Kamatar, A., Gunay, G., & Acar, H. (2020) · Polymers · doi:10.3390/polym12112506 · Cited by 104
Evolution of the Experimental Models of Cholangiocarcinoma
Massa, A., Varamo, C., Vita, F., Tavolari, S., Neia, C. P., Brandi, G., Rizzo, A., Cavalloni, G., & Aglietta, M. (2020) · Cancers · doi:10.3390/cancers12082308 · Cited by 96
Degradation of CCNK/CDK12 is a druggable vulnerability of colorectal cancer
Dieter, S. M., Siegl, C., Codó, P. L., Huerta, M., Ostermann-Parucha, A. L., Schulz, E., Zowada, M. K., Martin, S., Laaber, K., Nowrouzi, A., et al. (2021) · Cell Reports · doi:10.1016/j.celrep.2021.109394 · Cited by 95
Critical Role of Three-Dimensional Tumorsphere Size on Experimental Outcome
Singh, S. K., Abbas, S., Saxena, A. K., Tiwari, S., Sharma, L. K., & Tiwari, M. (2020) · BioTechniques · doi:10.2144/btn-2020-0081 · Cited by 95
Current Advances in 3D Bioprinting for Cancer Modeling and Personalized Medicine
Germain, N., Dhayer, M., Dekiouk, S., & Marchetti, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23073432 · Cited by 95
Mori, Y., Yamawaki, K., Ishiguro, T., Yoshihara, K., Ueda, H., Sato, A., Ohata, H., Yoshida, Y., Minamino, T., Okamoto, K., et al. (2019) · Stem Cell Reports · doi:10.1016/j.stemcr.2019.08.015 · Cited by 86
Current approaches in identification and isolation of cancer stem cells
Akbarzadeh, M., Maroufi, N. F., Tazehkand, A. P., Akbarzadeh, M., Bastani, S., Safdari, R., Farzane, A., Fattahi, A., Nejabati, H. R., Nouri, M., et al. (2019) · Journal of Cellular Physiology · doi:10.1002/jcp.28271 · Cited by 88
Mimicking Epithelial Tissues in Three-Dimensional Cell Culture Models
Torras, N., García-Díaz, M., Fernández‐Majada, V., & Martínez, E. (2018) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2018.00197 · Cited by 90
Eilenberger, C., Rothbauer, M., Selinger, F., Gerhartl, A., Jordan, C., Harasek, M., Schädl, B., Grillari, J., Weghuber, J., Neuhaus, W., et al. (2021) · Advanced Science · doi:10.1002/advs.202004856 · Cited by 86
Forte, E., Chimenti, I., Rosa, P., Angelini, F., Pagano, F., Calogero, A., Giacomello, A., & Messina, E. (2017) · Cancers · doi:10.3390/cancers9080098 · Cited by 86
Apigenin: Molecular Mechanisms and Therapeutic Potential against Cancer Spreading
Naponelli, V., Rocchetti, M. T., & Mangieri, D. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25105569 · Cited by 84
From 2D to 3D and beyond: the evolution and impact of in vitro tumor models in cancer research
Rauner, G., Gupta, P. B., & Kuperwasser, C. (2025) · Nature Methods · doi:10.1038/s41592-025-02769-1 · Cited by 76
Namba, Y., Sogawa, C. A., Okusha, Y., Kawai, H., Itagaki, M., Ono, K., Murakami, J., Aoyama, E., Ohyama, K., Asaumi, J., et al. (2018) · Frontiers in Oncology · doi:10.3389/fonc.2018.00376 · Cited by 78
Pozzi, S., Scomparin, A., Dangoor, S. I., Ajamil, D. R., Ofek, P., Neufeld, L., Krivitsky, A., Vaskovich‐Koubi, D., Kleiner, R., Dey, P., et al. (2021) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2021.04.001 · Cited by 74
Kim, D., Kim, M., Park, H.-B., Kim, K., & Kim, D.-E. (2019) · ACS Applied Bio Materials · doi:10.1021/acsabm.9b00705 · Cited by 67
Activation of Estrogen Receptor Alpha by Decitabine Inhibits Osteosarcoma Growth and Metastasis
Osuna, M. Á. L., García-López, J., Ayachi, I. E., Fatima, I., Khalid, A. B., Kumpati, J., Slayden, A. V., Seagroves, T. N., Miranda‐Carboni, G. A., & Krum, S. A. (2018) · Cancer Research · doi:10.1158/0008-5472.can-18-1255 · Cited by 65
Tataranni, T., Agriesti, F., Pacelli, C., Ruggieri, V., Laurenzana, I., Mazzoccoli, C., Sala, G. D., Panebianco, C., Pazienza, V., Capitanio, N., et al. (2019) · Cells · doi:10.3390/cells8050478 · Cited by 65
New Advances in the Study of Bone Tumors: A Lesson From the 3D Environment
Cortini, M., Baldini, N., & Avnet, S. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00814 · Cited by 65
Gradient-sized control of tumor spheroids on a single chip
Fang, G., Lu, H., Law, A. M. K., Gallego‐Ortega, D., Jin, D., & Lin, G. (2019) · Lab on a Chip · doi:10.1039/c9lc00872a · Cited by 64
Long, L., Hu, Y., Long, T., Lu, X., Tuo, Y., Li, Y., Wang, M., & Ke, Z. (2021) · Journal for ImmunoTherapy of Cancer · doi:10.1136/jitc-2021-003973 · Cited by 63
Conceição, F., Sousa, D. M., Loessberg-Zahl, J., Vollertsen, A. R., Neto, E., Søe, K., Paredes, J., Leferink, A., & Lamghari, M. (2022) · Materials Today Bio · doi:10.1016/j.mtbio.2022.100219 · Cited by 63
Miyazaki, T., Chung, S., Sakai, H., Ohata, H., Obata, Y., Shiokawa, D., Mizoguchi, Y., Kubo, T., Ichikawa, H., Taniguchi, H., et al. (2021) · Cancer Science · doi:10.1111/cas.15182 · Cited by 62
3D Tumor Spheroid and Organoid to Model Tumor Microenvironment for Cancer Immunotherapy
Zhu, Y., Kang, E., Wilson, M., Basso, T., Chen, E., Yu, Y., & Li, Y.-R. (2022) · Organoids · doi:10.3390/organoids1020012 · Cited by 63
Tumor organoids: From inception to future in cancer research
Yang, L., Yang, S., Li, X., Li, B., Li, Y., Zhang, X., Ma, Y., Peng, X., Jin, H., Fan, Q., et al. (2019) · Cancer Letters · doi:10.1016/j.canlet.2019.04.005 · Cited by 62
RHOA in Gastric Cancer: Functional Roles and Therapeutic Potential
Nam, S., Kim, J. H., & Lee, D. H. (2019) · Frontiers in Genetics · doi:10.3389/fgene.2019.00438 · Cited by 59
Azadi, S., Es, H. A., Bazaz, S. R., Thiery, J. P., Asadnia, M., & Warkiani, M. E. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.118526 · Cited by 59
Cavo, M., Cave, D. D., D’Amone, E., Gigli, G., Lonardo, E., & del Mercato, L. L. (2020) · Scientific Reports · doi:10.1038/s41598-020-66908-8 · Cited by 57
L1CAM promotes ovarian cancer stemness and tumor initiation via FGFR1/SRC/STAT3 signaling
Giordano, M., Decio, A., Battistini, C., Baronio, M., Bianchi, F., Villa, A., Bertalot, G., Freddi, S., Lupia, M., Jodice, M. G., et al. (2021) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-021-02117-z · Cited by 58
Recent advances in microfluidic technology and applications for anti-cancer drug screening
Shi, Y., Cai, Y., Cao, Y., Hong, Z., & Chai, Y. (2020) · TrAC Trends in Analytical Chemistry · doi:10.1016/j.trac.2020.116118 · Cited by 58
Arif, A., Alameri, A. A., Tariq, U. B., Ansari, S. A., Sakr, H. I., Qasim, M. T., Al-joborae, F. F. M., Ramírez‐Coronel, A. A., Jabbar, H. S., Gabr, G. A., et al. (2022) · International Immunopharmacology · doi:10.1016/j.intimp.2022.109581 · Cited by 61
Matsumoto, T., Yokoi, A., Hashimura, M., Oguri, Y., Akiya, M., & Saegusa, M. (2018) · Molecular Carcinogenesis · doi:10.1002/mc.22816 · Cited by 56
Three-Dimensional Cell Cultures as an In Vitro Tool for Prostate Cancer Modeling and Drug Discovery
Fontana, F., Raimondi, M., Marzagalli, M., Sommariva, M., Gagliano, N., & Limonta, P. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21186806 · Cited by 62
MTHFD1L, A Folate Cycle Enzyme, Is Involved in Progression of Colorectal Cancer
Agarwal, S., Behring, M. P., Hale, K., Diffalha, S. A., Wang, K., Manne, U., & Varambally, S. (2019) · Translational Oncology · doi:10.1016/j.tranon.2019.07.011 · Cited by 55
An omentum-inspired 3d peg hydrogel for identifying ecm-drivers of drug resistant ovarian cancer
Brooks, E. A., Gencoglu, M. F., Corbett, D. C., Stevens, K. R., & Peyton, S. R. (2019) · APL Bioengineering · doi:10.1063/1.5091713 · Cited by 51
Expression of Oncogenic Drivers in 3D Cell Culture Depends on Nuclear ATP Synthesis by NUDT5
Pickup, K. E., Pardow, F., Carbonell‐Caballero, J., Lioutas, A., Villanueva‐Cañas, J. L., Wright, R. H. G., & Beato, M. (2019) · Cancers · doi:10.3390/cancers11091337 · Cited by 52
Kwon, S., Jung, S., & Baek, S. H. (2023) · Antioxidants · doi:10.3390/antiox12040924 · Cited by 52
Patient-derived Models Reveal Impact of the Tumor Microenvironment on Therapeutic Response
Shafi, A. A., Schiewer, M. J., de Leeuw, R., Dylgjeri, E., McCue, P. A., Shah, N., Gomella, L. G., Lallas, C. D., Trabulsi, E. J., Centenera, M. M., et al. (2018) · European Urology Oncology · doi:10.1016/j.euo.2018.04.019 · Cited by 51
Namekawa, T., Ikeda, K., Horie‐Inoue, K., Suzuki, T., Okamoto, K., Ichikawa, T., Yano, A., Kawakami, S., & Inoue, S. (2019) · International Journal of Cancer · doi:10.1002/ijc.32505 · Cited by 51
Lv, L., Li, Q., Chen, S., Zhang, X., Tao, X., Tang, X., Wang, S., Che, G., Yu, Y., & He, L. (2019) · Experimental Cell Research · doi:10.1016/j.yexcr.2019.111597 · Cited by 52
A 3D Spheroid Model for Glioblastoma
Guyon, J., Andrique, L., Pujol, N., Røsland, G. V., Recher, G., Bikfalvi, A., & Daubon, T. (2020) · Journal of Visualized Experiments · doi:10.3791/60998 · Cited by 64
CXCR4 Inhibition Counteracts Immunosuppressive Properties of Metastatic NSCLC Stem Cells
Fortunato, O., Belisario, D. C., Compagno, M., Giovinazzo, F., Bracci, C., Pastorino, U., Horenstein, A. L., Malavasi, F., Ferracini, R., Scala, S., et al. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.02168 · Cited by 49
Soubéran, A., & Tchoghandjian, A. (2020) · Cancers · doi:10.3390/cancers12092347 · Cited by 52
Role of the NUDT Enzymes in Breast Cancer
Wright, R. H. G., & Beato, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22052267 · Cited by 50
Non-animal models in dermatological research
Dellambra, E. (2018) · ALTEX · doi:10.14573/altex.1808022 · Cited by 49
Radiation-induced DNA damage response and resistance in colorectal cancer stem-like cells
Anuja, K., Chowdhury, A. R., Saha, A., Roy, S., Rath, A. K., Kar, M., & Banerjee, B. (2019) · International Journal of Radiation Biology · doi:10.1080/09553002.2019.1580401 · Cited by 47
LKB1 and cancer: The dual role of metabolic regulation
Li, T., & Zhu, H. (2020) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2020.110872 · Cited by 47
Roy, S. M., Garg, V., Barman, S., Ghosh, C., Maity, A. R., & Ghosh, S. K. (2021) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2021.785937 · Cited by 49
Lee, H., Chiou, J.-F., Wang, P., Lu, L., Shen, C., Hsu, H.-L., Burnouf, T. P. R., Ting, L., Chou, P.-C., Chung, C., et al. (2020) · Cancers · doi:10.3390/cancers12113394 · Cited by 45
Direct interaction of β‐catenin with nuclear ESM1 supports stemness of metastatic prostate cancer
Pan, K., Lee, W.-J., Chou, C., Yang, Y., Chang, Y., Chien, M., Hsiao, M., & Hua, K. (2020) · The EMBO Journal · doi:10.15252/embj.2020105450 · Cited by 43
Zhang, Y., Wang, Z., Hu, Q., Luo, H., Lu, B., Gao, Y., Qiao, Z., Zhou, Y., Fang, Y., Gu, J., et al. (2022) · Small · doi:10.1002/smll.202200364 · Cited by 46
Pustovalova, M. V., Blokhina, T., Alhaddad, L., Chigasova, A. K., Chuprov‐Netochin, R. N., Veviorskiy, A., Filkov, G. I., Osipov, A. N., & Leonov, S. V. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23094922 · Cited by 46
Adaptive phenotypic modulations lead to therapy resistance in chronic myeloid leukemia cells
Baykal, S., Açıkgöz, E., Yavuz, A. S., Geyik, Ö. G., Ateş, H., Sezerman, O. U., Özsan, G. H., & Yüce, Z. (2020) · PLoS ONE · doi:10.1371/journal.pone.0229104 · Cited by 44
Folate can promote the methionine-dependent reprogramming of glioblastoma cells towards pluripotency
Zgheib, R., Battaglia-Hsu, S.-F., Hergalant, S., Quéré, M., Alberto, J., Chéry, C., Rouyer, P., Gauchotte, G., Guéant, J., & Namour, F. (2019) · Cell Death and Disease · doi:10.1038/s41419-019-1836-2 · Cited by 44
Intrinsic and Extrinsic Factors Impacting Cancer Stemness and Tumor Progression
Ponomarev, A., Gilazieva, Z., Solovyeva, V. V., Allegrucci, C., & Rizvanov, A. A. (2022) · Cancers · doi:10.3390/cancers14040970 · Cited by 45
Foglizzo, V., Cocco, E., & Marchiò, S. (2022) · Cancers · doi:10.3390/cancers14153692 · Cited by 48
Peperstraete, E., Lecerf, C., Collette, J., Vennin, C., Raby, L., Völkel, P., Angrand, P., Winter, M., Bertucci, F., Finetti, P., et al. (2020) · Cancers · doi:10.3390/cancers12071730 · Cited by 42
Exosomes, metastases, and the miracle of cancer stem cell markers
Wang, Z., & Zöller, M. (2019) · Cancer and Metastasis Reviews · doi:10.1007/s10555-019-09793-6 · Cited by 41
TRIB3 promotes lung cancer progression by activating β-catenin signaling
Zhang, X., Zhong, N., Li, X., & Chen, M. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.172697 · Cited by 41
Engineering complexity in human tissue models of cancer
Ronaldson-Bouchard, K., Baldassarri, I., Tavakol, D. N., Graney, P. L., Samaritano, M., Cimetta, E., & Vunjak‐Novakovic, G. (2022) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2022.114181 · Cited by 43
Terraneo, N., Jacob, F., Peitzsch, C., Dubrovska, A., Krudewig, C., Huang, Y., Heinzelmann-Schwarz, V. A., Schibli, R., Béhé, M. P., & Grünberg, J. (2020) · Cancers · doi:10.3390/cancers12010217 · Cited by 40
The hedgehog pathway regulates cancer stem cells in serous adenocarcinoma of the ovary
Sneha, S., Nagare, R. P., Sidhanth, C., Krishnapriya, S., Garg, M., Ramachandran, B., Murhekar, K. M., Sundersingh, S., & Ganesan, T. S. (2020) · Cellular Oncology · doi:10.1007/s13402-020-00504-w · Cited by 40
Panoutsopoulos, A. A. (2020) · The Neuroscientist · doi:10.1177/1073858420960112 · Cited by 42
Yang, Y., Wu, J., Liu, F., He, J. H., Wu, F., Chen, J., & Jiang, Z. (2021) · Stem Cells and Development · doi:10.1089/scd.2021.0153 · Cited by 41
Modeling glioblastoma complexity with organoids for personalized treatments
Pawlowski, K. D., Duffy, J. T., Babak, M. V., & Balyasnikova, I. V. (2023) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2023.01.002 · Cited by 42
Overcoming drug resistance with a docetaxel and disulfiram loaded pH-sensitive nanoparticle
Swetha, K. L., Paul, M., Maravajjala, K. S., Kumbham, S., Biswas, S., & Roy, A. (2023) · Journal of Controlled Release · doi:10.1016/j.jconrel.2023.02.023 · Cited by 39
Guerreiro, J. F., Gomes, M. A. G. B., Pagliari, F., Jansen, J., Marafioti, M. G., Nisticò, C., Hanley, R., Costa, R. O., Ferreira, S. S., Mendes, F., et al. (2020) · RSC Advances · doi:10.1039/d0ra00166j · Cited by 39
KLF7: a new candidate biomarker and therapeutic target for high-grade serous ovarian cancer
Donato, M. D., Babini, G., Mozzetti, S., Buttarelli, M., Ciucci, A., Arduini, G., Rosa, M. C. D., Scambia, G., & Gallo, D. (2020) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-020-01775-9 · Cited by 39
Visualizing Extracellular Vesicles and Their Function in 3D Tumor Microenvironment Models
Ural, E. E., Toomajian, V., Apu, E. H., Veletić, M., Balasingham, I., Ashammakhi, N. A., Kanada, M., & Contag, C. H. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22094784 · Cited by 38
Huang, X., Zhang, S., Tang, J., Tian, T., Pan, Y., Wu, L., Zhang, J., Liu, Y., Huang, J., Dai, H., et al. (2023) · Cancer Research · doi:10.1158/0008-5472.can-22-2733 · Cited by 38
Lee, T. W., Lai, A., Harms, J. K., Singleton, D. C., Dickson, B. D., Macann, A., Hay, M. P., & Jamieson, S. M. F. (2020) · Cancers · doi:10.3390/cancers12123743 · Cited by 38
A Self-Assembling Amphiphilic Peptide Dendrimer-Based Drug Delivery System for Cancer Therapy
Zhu, D., Zhang, H., Huang, Y., Lian, B., Ma, C., Han, L., Chen, Y., Wu, S., Li, N., Zhang, W., et al. (2021) · Pharmaceutics · doi:10.3390/pharmaceutics13071092 · Cited by 37
Yamawaki, K., Mori, Y., Sakai, H., Kanda, Y., Shiokawa, D., Ueda, H., Ishiguro, T., Yoshihara, K., Nagasaka, K., Onda, T., et al. (2021) · Cancer Letters · doi:10.1016/j.canlet.2021.08.018 · Cited by 37
Fernández-García, E., Paudel, U., Noji, M., Bowman, C. E., Pitarresi, J. R., Rustgi, A. K., Wellen, K. E., Arany, Z. P., Weissenrieder, J., & Foskett, J. K. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1082213 · Cited by 35
Organoids Provide an Important Window on Inflammation in Cancer
Baker, K. (2018) · Cancers · doi:10.3390/cancers10050151 · Cited by 37
Dzobo, K., Rowe, A., Senthebane, D. A., AlMazyadi, M., Patten, V. A., & Parker, M. I. (2018) · OMICS A Journal of Integrative Biology · doi:10.1089/omi.2018.0172 · Cited by 37
Naseri, M., Zöller, M., Hadjati, J., Ghods, R., Pirmardan, E. R., Kiani, J., Eini, L., Bozorgmehr, M., & Madjd, Z. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16401 · Cited by 36
Uno, K., Iyoshi, S., Yoshihara, M., Kitami, K., Mogi, K., Fujimoto, H., Sugiyama, M., Koya, Y., Yamakita, Y., Nawa, A., et al. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23084383 · Cited by 36
Precision Medicine in Head and Neck Cancers: Genomic and Preclinical Approaches
Miserocchi, G., Spadazzi, C., Calpona, S., Rosa, F. D., Usai, A., Vita, A. D., Liverani, C., Cocchi, C., Vanni, S., Calabrese, C., et al. (2022) · Journal of Personalized Medicine · doi:10.3390/jpm12060854 · Cited by 36
Muenzner, J. K., Kunze, P., Lindner, P., Polaschek, S., Menke, K., Eckstein, M., Geppert, C. I., Pithi Chanvorachote, B., Bäuerle, T., Hartmann, A., et al. (2018) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.13911 · Cited by 37
Metadata
- Authors
- Ishiguro, T., Ohata, H., Sato, A., Yamawaki, K., Enomoto, T., & Okamoto, K.
- Affiliations
- Niigata University (JP)
- National Cancer Center Research Institute (JP)
- Corresponding author
- Okamoto, Koji
- Venue
- Cancer Science
- Publisher
- Wiley
- Published
- 2017-03
- Volume
- 108
- Issue
- 3
- Pages
- 283-289
- ISSN
- 1347-9032 (ISSN-L)
- 1349-7006
- PMC
- PMC5378268
- OpenAlex
- W2570959155
- Cited by
- 530
- References
- 80
- Citations by year
- 2026: 35 · 2025: 59 · 2024: 67 · 2023: 69 · 2022: 64 · 2021: 65 · 2020: 70 · 2019: 55 · 2018: 33 · 2017: 11
- FWCI
- 4.85
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- Cancer Science (publishedVersion, cc-by-nc)
- PubMed Central (publishedVersion, cc-by-nc)
- PubMed (publishedVersion)
- Institutional Repositories DataBase (IRDB) (submittedVersion)
- Funders
- Ministry of Education, Culture, Sports, Science and Technology
- National Cancer Center
- Japan Society for the Promotion of Science
- Japan Agency for Medical Research and Development
- Topics
- Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
- Physical Sciences › Engineering › Biomedical Engineering › 3D Printing in Biomedical Research
- Physical Sciences › Mathematics › Modeling and Simulation › Mathematical Biology Tumor Growth
- Keywords
- cancer stem cells, tumor spheroids, tumor organoids, chemoresistance, tumorigenicity, high-throughput screening, circulating tumor cells, glioma, breast cancer, colon cancer, ovarian cancer, prostate cancer
- MeSH terms
- Humans, Neoplasms, Tumor Cells, Cultured, Neoplastic Stem Cells, Spheroids, Cellular, Cell Culture Techniques
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
